EUVIMEDEUVIMED entdecken
Crossref

Clinical Significance of Immunohistochemistry (IHC) in the Diagnosis and Prognosis of Breast Cancer

Nehapriya Sinha, Vibha Rani, Aman Raj, Awadhesh Kumar, Imtiaz Ahmad

International Journal of Pharmaceutical Quality Assurance · 11.07.2026 · 16 (12)

DOI: 10.25258/ijpqa.16.12.106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 11.07.2026. Verfasst von Nehapriya Sinha und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

.

Zitieren

APA

Sinha, N., Rani, V., Raj, A., Kumar, A., & Ahmad, I. (2026). Clinical Significance of Immunohistochemistry (IHC) in the Diagnosis and Prognosis of Breast Cancer. International Journal of Pharmaceutical Quality Assurance, 16(12). https://doi.org/10.25258/ijpqa.16.12.106

Vancouver

Sinha N, Rani V, Raj A, Kumar A, Ahmad I. Clinical Significance of Immunohistochemistry (IHC) in the Diagnosis and Prognosis of Breast Cancer. International Journal of Pharmaceutical Quality Assurance. 2026;16(12). doi:10.25258/ijpqa.16.12.106

BibTeX
@article{Sinha2026,
  author = {Sinha, Nehapriya and Rani, Vibha and Raj, Aman and Kumar, Awadhesh and Ahmad, Imtiaz},
  title = {Clinical Significance of Immunohistochemistry (IHC) in the Diagnosis and Prognosis of Breast Cancer},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {16},
  number = {12},
  doi = {10.25258/ijpqa.16.12.106}
}
Kostenlos starten →